BFM
CPIX icon

Boothbay Fund Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Boothbay Fund Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$415K Sell
127,694
-813
-0.6% -$3.13K 0.01% 1443
2025
Q4 		$511K Sell
128,507
-39,625
-24% -$117K 0.01% 1130
2025
Q3 		$525K Sell
168,132
-12,097
-7% -$40.2K 0.01% 1130
2025
Q2 		$604K Sell
180,229
-43,569
-19% -$206K 0.01% 847
2025
Q1 		$947K Buy
+223,798
New +$928K 0.02% 653

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boothbay Fund Management's CPIX Position: Q1 2026 in Review

Boothbay Fund Management reduced its Cumberland Pharmaceuticals (CPIX) stake by 0.63% in Q1 2026, selling an estimated $3.13K and leaving 127,694 shares worth $415K. The position accounts for 0.01% of the portfolio, ranked #1443.

Boothbay Fund Management first reported a position in CPIX in Q1 2025 and has held it in 5 quarters since. The position peaked at $947K in Q1 2025. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Boothbay Fund Management held 127,694 shares of Cumberland Pharmaceuticals worth $415K as of Q1 2026.
  • Boothbay Fund Management sold 813 Cumberland Pharmaceuticals shares in Q1 2026, an estimated $3.13K.
  • Cumberland Pharmaceuticals made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1443 holding.
  • Boothbay Fund Management first reported a position in Cumberland Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Boothbay Fund Management's Cumberland Pharmaceuticals position peaked at $947K in Q1 2025.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.